Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation

American Journal of Cardiology

Volumn 84, Issue 1, 1999, Pages 104-108

  Frick, Mats ^a   Östergren, Jan ^a   Rosenqvist, Mårten ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; MAGNESIUM; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE VARIABILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAGNESIUM BLOOD LEVEL; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; SKIN MANIFESTATION; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM; MALE;

EID: 0033055704     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00204-0     Document Type: Article

References (20)

1. Naito M., David D., Michelson E.L., Schaffenburg M., Dreifus L.S. The hemodynamic concequences of cardiac arhythmias evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model . Am Heart J. 106:1983;284-291.
2. David M.C., Vance J.P., Andrew E.E., Neal K. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 30:1997;1039-1045.
3. Schneider F., David T.M., Shick E.C., Gaasch W.H. Interval-dependent changes in left ventricular contractile state in lone atrial fibrillation and in atrial fibrillation associated with coronary artery 0disease. Am J Cardiol. 80:1997;586-590.
4. James M.A., Channer K.S., Papouchado M., Rees J.R. Improved control of atrial fibrillation with combined pindolol and digoxin therapy. Eur Heart J. 10:1989;83-90.
5. Channer K.S., Papouchado M., James M.A., Pitcher D.W. Towards improved control of atrial fibrillation. Eur Heart J. 8:1987;141-147.
6. Hnatkova K., Murgatroyd F.D., Cemm A.J., Malik M. Effect of digoxin on the ventricular rate variability during paroxysmal atrial fibrillation. Pacing Electrophysiol. 19:1996;1968-1971.
7. Kulick D.L., Hong R., Ryzen E., Rude R.K., Rubin J.N., Elkayam U., Rahimtoola S.H., Bhandari A.K. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of cardiac disease. Am Heart J. 115:1988;367-373.
8. DiCarlo L.A., Morady F., Buitleir M., Krol R.B., Schurig L., Annesley T.M. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol. 7:1986;1356-1362.
9. Perticone F., Ceravalo R., Costa R., Mattioli P.L. Electrophysiologic effects of magnesium sulfate infusion in patients with cardiac conduction defects. J Am Coll Nutrition. 11:1992;405-409.
10. Sager P., Widehorn J., Petersen R., Leon C., Ryzen E., Rude R., Rahimtoola S., Bhandari A. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia. Am Heart J. 119:1990;308-316.
11. Viskin S., Belhassen B., Sheps D., Laniado S. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphospate. Am J Cardiol. 70:1992;879-885.
12. Wesley R.C., Haines D.E., Lerman B., Dimarco J.P., Cramton R.S. Effect of magnesium sulfate on supraventricular tachycardia. Am J Cardiol. 63:1989;1129-1131.
13. Gullestad L., Birkeland K., Molstad P., Hoyer M.M., Vanberg P., Kjekshus J. The effect of magnesium versus verapamil on supraventricular arrhythmias. Clin Cardiol. 16:1993;429-434.
14. Moran J.L., Gallagher J., Peake S.L., Cunningham D.N., Salagaras M., Leppard P. Parenteral magnesium sulfate versus amiodaron in therapy of atrial tachyarrhythmias a prospective, randomized study . Crit Care Med. 23:1995;1816-1824.
15. Nygårds M.E., AhrenT Tranesj, ö J., Wigertz O. A computer program for analysis of longterm ECG recordings. In: Computers in Cardiology. 1984;429-432 IEEE Computer Society, Long Beach, CA.
16. Bergfeldt L.B., Edhag K.O., Solders G., Valiin H.O. Analysis of sinus cycle variation a new method for evaluation of suspected sinus node dysfunction . Am Heart J. 114:1987;321-327.
17. Brodsky M.A., Orlov M.V., Caparelli E.V., Allen B.J., Iseri L.T., Ginkel M., Orlov Y. Magnesium therapy in new-onset atrial fibrillation. Am J Cardiol. 73:1994;1227-1229.
18. Boyd L.J. Magnesium sulfate in paroxysmal tachycardia. Am J Med Sci. 206:1943;43-48.
19. Szekely P. The action of magnesium on the heart. Br Heart J. 8:1946;115-124.
20. Enselberg C.D., Simmons H.G., Mintz A.A. The effects of magnesium upon cardiac arrhythmias. Am Heart J. 39:1950;703-712.